Assessment of Tiredness During Awake Resection of Intracerebral Tumors
NCT ID: NCT06922487
Last Updated: 2025-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10 participants
OBSERVATIONAL
2024-11-11
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this single center study is to use the "Karolinska Sleepiness Scale" during and after awake surgery for neurosurgical tumor resection to quantify the time available for surgical intervention.
Participants are adults having planned surgery for open resection of intracranial tumor with a planned awakening for assessment during surgery. Participants will be asked to grade postoperative sleepiness using the "Karolinska Sleepiness Scale".
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep-Disordered Breathing in the Acute Phase After Stroke and Neuropsychiatric Outcomes
NCT06811948
Association Between Preoperative Insomnia and Postoperative Quality of Recovery : A Prospective Observational Study
NCT06008873
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NCT06457945
Call- Associated Acute Fatigue in Surgical Residency
NCT01284842
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
NCT04419792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods Ethical review board approval (Dnr 2024-01935-01, Stockholm, Sweden) is present.
The study is a single center kohort study.
Participants will be identified by the neurosurgeon planning tumor resection with intraoperative awake surgery. Inclusion and information are given preoperatively by the neurosurgeon and the anesthetist.
All participants receive propofol/remifentanil based general anesthesia with norepinephrine infusion to support blood-pressure during preparation and craniotomy whereafter the participant is awakened. The resection starts when the participant is coherent and cooperative. Peroperative level of sedation is assessed using Karolinska Sleepiness Scale (KSS) every 15 minutes. KSS is an ordinal nine grade scale assessing sleepiness during the last five minutes from "extremely alert" to "very sleepy, great effort to keep awake, fighting sleep". When the resection is completed the participants receives general anesthesia during wound closure. Postoperative level of sedation is assessed using Karolinska Sleepiness Scale (KSS) during the first two postoperative hours.
Data regarding age, sex, length, weight, comorbidities, tumor location, ASA- classification and preoperative medication will be collected. Peroperative vital parameters and pEEG -results and data from infusion pumps are primarily collected electronically. The manually kept anesthetic notes are copied and stored as back-up. All individual data are de-identified and coded after collection.
Inclusion and exclusion criteria Inclusion Adult (\>18 years old) Elective supra or infratentorial tumor resection via craniotomy Surgical need for awake surgery Cognitive function allowing informed consent.
Exclusion Tumor localization not allowing placement of BIS electrodes due to interference with surgery Morbid obesitas
Outcomes Peroperative degree of sleepiness measured with Karolinska Sleepiness Scale (KSS).
Statistical methods and power calculation The study is a descriptive cohort study. A convenience sample of participants fulfilling inclusion criteria during the inclusion time will be used. The primary goal is to include at least 10 participants. As primary KSS variable a deviation of two or more units will be considered a significant change. Time from start of resection until significant change in KSS is the primary endpoint.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
awake surgery
intracranial tumor resection via awake surgery, adult.
Karolinska Sleepiness Scale, KSS
Assessment of sleepiness during resection using KSS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Karolinska Sleepiness Scale, KSS
Assessment of sleepiness during resection using KSS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective supra or infratentorial tumor resection via craniotomy
* Surgical need for awake surgery
* Cognitive function allowing informed consent.
Exclusion Criteria
* Morbid obesitas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malin Rundgren, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Anaesthesia and Intensive Care, Skane University hospital, Lund, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intensive and Perioperative Care, Skane University Hospital
Lund, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-01935-01 study 4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.